EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Prognostic Utility of the Total Body Muscle Mass in Heart Failure: Insights From the JEDI ‐ AHF Registry

Yoshiaki Ikeda, Taisuke Nakade, Yuya Matsue, Yudai Fujimoto, Yutaka Nakamura, Yuka Akama, Daichi Maeda, Tsutomu Sunayama, Taishi Dotare, Shoichiro Yatsu, Sayaki Ishiwata, Shoko Suda und 4 weitere

Geriatrics & Gerontology International · 2026

DOI: 10.1111/ggi.70680 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Geriatrics & Gerontology International, 2026. Verfasst von Yoshiaki Ikeda und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Heart Failure, Creatinine, Body Weight, Cystatin C. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Society for the Promotion of Science (JSPS) KAKENHI, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Quantifying skeletal muscle mass is essential for patients with heart failure; however, common modalities, such as bioelectrical impedance analysis, can be distorted by fluid retention. The total body muscle mass (TBMM), a creatinine–cystatin C‐derived marker, has been proposed as a practical blood‐based surrogate of muscle mass; however, its relationship with muscle mass and its prognostic value in acute heart failure remain uncertain. Therefore, we aimed to assess whether TBMM is associated with skeletal muscle mass indices in heart failure and postdischarge all‐cause mortality in patients hospitalized for acute heart failure.

Methods

This single‐center retrospective study included patients hospitalized for acute heart failure at Juntendo University Hospital (January 2015–December 2021). TBMM was calculated from body weight, serum creatinine, and cystatin C, and classified using prespecified sex‐specific cut‐offs (men, < 38.846; women, < 26.476).

Results

Among the 550 patients, 271 had low TBMM. Over a median follow‐up of 2.6 years, 134 deaths occurred (low‐TBMM, 79; high‐TBMM, 55). Patients with low TBMM showed significantly lower survival and a higher risk of postdischarge mortality after adjustment. Findings were consistent across the left ventricular ejection fraction strata (< 50% and ≥ 50%). TBMM correlated strongly with appendicular skeletal muscle mass index, estimated using both anthropometric and biomarker‐based models.

Conclusions

In patients hospitalized for acute heart failure, TBMM was strongly correlated with estimated muscle mass and independently associated with postdischarge all‐cause mortality. Therefore, TBMM may complement routine risk stratification and help identify patients with heightened vulnerability related to muscle impairment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureCreatinineBody WeightCystatin CMuscle, SkeletalRegistriesHumansMaleFemaleAgedAged, 80 and overRetrospective StudiesBiomarkersPrognosisHospitalizationSarcopeniaAnthropometryRisk AssessmentFollow-Up Studies

Stichwörter der Autor:innen

acute heart failureappendicular skeletal muscle mass indexsarcopeniaskeletal muscle masstotal body muscle mass

Substanzen

CreatinineCystatin CBiomarkers

Autor:innen und Institutionen

  • Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Department of Cardiology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

ORCID-Profile: Takatoshi Kasai

Förderung

  • Japan Society for the Promotion of Science (JSPS) KAKENHI
  • Japan Society for the Promotion of Science

Zitieren

APA

Ikeda, Y., Nakade, T., Matsue, Y., Fujimoto, Y., Nakamura, Y., Akama, Y., Maeda, D., Sunayama, T., Dotare, T., Yatsu, S., Ishiwata, S., Suda, S., Kato, T., Hiki, M., Kasai, T., & Minamino, T. (2026). Prognostic Utility of the Total Body Muscle Mass in Heart Failure: Insights From the JEDI ‐ AHF Registry. Geriatrics & Gerontology International. https://doi.org/10.1111/ggi.70680

Vancouver

Ikeda Y, Nakade T, Matsue Y, Fujimoto Y, Nakamura Y, Akama Y, et al. Prognostic Utility of the Total Body Muscle Mass in Heart Failure: Insights From the JEDI ‐ AHF Registry. Geriatrics & Gerontology International. 2026. doi:10.1111/ggi.70680

BibTeX
@article{Ikeda2026,
  author = {Ikeda, Yoshiaki and Nakade, Taisuke and Matsue, Yuya and Fujimoto, Yudai and Nakamura, Yutaka and Akama, Yuka and Maeda, Daichi and Sunayama, Tsutomu and Dotare, Taishi and Yatsu, Shoichiro and Ishiwata, Sayaki and Suda, Shoko and Kato, Takao and Hiki, Masaru and Kasai, Takatoshi and Minamino, Tohru},
  title = {Prognostic Utility of the Total Body Muscle Mass in Heart Failure: Insights From the JEDI ‐ AHF Registry},
  journal = {Geriatrics & Gerontology International},
  year = {2026},
  doi = {10.1111/ggi.70680}
}
Kostenlos starten →